Illustrative synthetic data — not real Level AI or customer data
Forecast Evidence Engine

All deals/Meridian Health Systems

Enterprise · Proposal · close Sep 30 2026

Meridian Health Systems

Amira Soltani · opp-hidden-competitor

$510,000

Best CaseBest Case

MEDDICC

81.3

6.5 of 8 points

Days since last meaningful call

7 days

call-meridian-3

External voices

3

Economic buyer on a call: yes

Evidence gate

Passed — category stands.

RepBest CaseAdjustedBest Case

Gate result

Meridian Health Systems stays in Best Case. The evidence gate does not promote deals; it only demotes unsupported Commit and Best Case calls.

Evidence freshness

Last meaningful external call was 7 days ago. Commit requires a meaningful external call within 14 days. 0 short call(s) were ignored.

Economic buyer on a call

Dr. Anil Kapoor is named in CRM and appears on a call as Dr. Anil Kapoor.

MEDDICC completeness

Score 81.3 / 100 from 6.5 of 8 points. 6 field(s) corroborated on a call (1.0 each), 1 CRM-only (0.5 each), 1 absent (0).

  • Metrics: call — Nurse-line QA coverage from 6% to 80%
  • Economic buyer: call — Dr. Anil Kapoor, COO
  • Decision criteria: call — HIPAA, after-call scoring, EHR notes
  • Decision process: call — Clinical ops committee, then COO
  • Paper process: crm — BAA required; legal has a 4-week SLA
  • Identified pain: call — Compliance sampling misses most nurse-line risk
  • Champion: call — Maya Chen, Director of Clinical Ops
  • Competition: absent

Multi-threading

3 distinct external participant(s) (seniority-weighted score 6.5): Dr. Anil Kapoor, Maya Chen, Owen Briggs.

  • Call call-meridian-1 — Dr. Anil Kapoor (c-level) on call-meridian-1, call-meridian-3
  • Call call-meridian-1 — Maya Chen (director) on call-meridian-1, call-meridian-2, call-meridian-3
  • Call call-meridian-2 — Owen Briggs (manager) on call-meridian-2

MEDDICC grid

Call evidence counts 1.0, CRM-only 0.5, absent 0.

81.3 / 100

Metrics

Call evidence

Nurse-line QA coverage from 6% to 80%

1 pt

Economic buyer

Call evidence

Dr. Anil Kapoor, COO

1 pt

Decision criteria

Call evidence

HIPAA, after-call scoring, EHR notes

1 pt

Decision process

Call evidence

Clinical ops committee, then COO

1 pt

Paper process

CRM only

BAA required; legal has a 4-week SLA

0.5 pt

Identified pain

Call evidence

Compliance sampling misses most nurse-line risk

1 pt

Champion

Call evidence

Maya Chen, Director of Clinical Ops

1 pt

Competition

Absent

No value recorded.

0 pt

Call timeline

Calls under 3 minutes are not meaningful for freshness.

  1. Meridian COO discovery — nurse-line QA

    Aug 11 2026 · 48 min · call-meridian-1

    Meaningful · External: Dr. Anil Kapoor (c-level), Maya Chen (director)

    Dr. Kapoor owns the budget. Maya described 6% sampling on the nurse line. They asked for a HIPAA architecture overview.

  2. Clinical ops working session

    Aug 20 2026 · 39 min · call-meridian-2

    Meaningful · External: Maya Chen (director), Owen Briggs (manager)

    Maya said they are also evaluating Voxora Replay and asked for a side-by-side on after-call scoring versus live assist.

    • evaluating Voxora Replay

  3. Proposal readout with COO

    Aug 27 2026 · 32 min · call-meridian-3

    Meaningful · External: Dr. Anil Kapoor (c-level), Maya Chen (director)

    Kapoor liked the coverage number. Maya repeated that Voxora Replay is in the committee packet and legal has a 4-week BAA SLA.

    • Voxora Replay is in the committee packet